Insulet Corp: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on May 6, 2022 and accepted by EDGAR at May 5, 2022, 17:55 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $247.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-01-01 to 2022-03-31 | $85.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-01-01 to 2022-03-31 | $209.7m | us-gaap:GrossProfit |
| Research and development | 3 months2022-01-01 to 2022-03-31 | $43.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | $37.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-01-01 to 2022-03-31 | $9.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-01-01 to 2022-03-31 | $1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | $27.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | $0.40 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | $0.40 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 69,858,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-01-01 to 2022-03-31 | −$13.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-01-01 to 2022-03-31 | $12.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2022-03-31 | $1.29bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $2.07bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $215.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $1.62bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-03-31 | $1.39bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-03-31 | $25.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-03-31 | $446.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-22-000027. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.